TC
AZN icon

TownSquare Capital’s AstraZeneca AZN Stock Holding History

TownSquare Capital’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$257K Buy
1,354
+10
+0.7% +$1.88K 0.05% 241
2026
Q1 		$265K Sell
1,344
-179
-12% -$34.5K 0.06% 209
2025
Q4 		$280K Sell
1,523
-606
-28% -$106K 0.06% 204
2025
Q3 		$327K Sell
2,129
-2,483
-54% -$376K 0.05% 276
2025
Q2 		$645K Sell
4,612
-36,539
-89% -$5.12M 0.06% 300
2025
Q1 		$6.05M Sell
41,151
-3,137
-7% -$454K 0.06% 281
2024
Q4 		$5.8M Buy
44,288
+1,103
+3% +$154K 0.07% 278
2024
Q3 		$6.73M Buy
43,185
+15,477
+56% +$2.5M 0.08% 245
2024
Q2 		$4.32M Buy
27,708
+4,058
+17% +$611K 0.06% 300
2024
Q1 		$3.2M Buy
23,650
+1,134
+5% +$150K 0.05% 345
2023
Q4 		$3.03M Buy
22,516
+7,778
+53% +$1.01M 0.05% 335
2023
Q3 		$2M Buy
14,738
+9,226
+167% +$1.26M 0.04% 404
2023
Q2 		$789K Buy
5,512
+1,078
+24% +$159K 0.01% 620
2023
Q1 		$616K Buy
4,434
+189
+4% +$25.4K 0.01% 609
2022
Q4 		$576K Buy
4,245
+2,262
+114% +$284K 0.01% 595
2022
Q3 		$217K Buy
+1,983
New +$252K 0.01% 672
2020
Q4 		– Sell
-1,921
Closed -$206K – 496
2020
Q3 		$206K Sell
1,921
-91
-5% -$10.1K 0.01% 396
2020
Q2 		$214K Sell
2,012
-1,084
-35% -$112K 0.01% 373
2020
Q1 		$321K Sell
3,096
-869
-22% -$81.8K 0.03% 323
2019
Q4 		$396K Buy
3,965
+29
+0.7% +$2.73K 0.03% 313
2019
Q3 		$368K Sell
3,936
-219
-5% -$19K 0.03% 355
2019
Q2 		$368K Sell
4,155
-464
-10% -$36.4K 0.04% 337
2019
Q1 		$373K Buy
4,619
+1,416
+44% +$112K 0.03% 321
2018
Q4 		$237K Buy
+3,203
New +$250K 0.03% 329

Other funds holding AZN

EP
Evelyn Partners London $46.9B AUM
IA
Investor AB Stockholm, Sweden $14.4B AUM 4.07% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

TownSquare Capital's AZN Position: Q2 2026 in Review

TownSquare Capital increased its AstraZeneca (AZN) stake by 0.74% in Q2 2026, buying an estimated $1.88K and bringing the position to 1,354 shares worth $257K. The position accounts for 0.05% of the portfolio, ranked #241.

TownSquare Capital first reported a position in AZN in Q4 2018 and has held it in 24 quarters since. The position peaked at $6.73M in Q3 2024. 1,502 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

  • TownSquare Capital held 1,354 shares of AstraZeneca worth $257K as of Q2 2026.
  • TownSquare Capital bought 10 AstraZeneca shares in Q2 2026, an estimated $1.88K.
  • AstraZeneca made up 0.05% of TownSquare Capital's portfolio in Q2 2026, its #241 holding.
  • TownSquare Capital first reported a position in AstraZeneca in Q4 2018 and has held it in 24 quarters since.
  • TownSquare Capital's AstraZeneca position peaked at $6.73M in Q3 2024.
  • 1,502 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on TownSquare Capital's 13F filing for Q2 2026, filed 14 Aug 2026.